Please ensure Javascript is enabled for purposes of website accessibility

News

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (th...

National COVID-19 Clinical Evidence Taskforce Guidelines

The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update ...

ARES Study published

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

2023 S&E Research Grants Awarded

This year THANZ awarded S&E Research Grants to the following members Gabriella Pennings (ANZAC Research Institute/Sydney Local Health District)Mechanism/s of acute IL-1β release...

2023 S&E Travel Grants Awarded

This year THANZ awarded 4 S&E Travel Grants to the following members Yvonne Kong who will travel to the University of Pavia, Italy Hannah Stevens will travel to the University of...

National Statement for the Emergency Use of Group O Red Blood Cells

The National Blood Authority is pleased to advise that the National Statement for the Emergency Use of Group O Red Blood Cells is now available on the National Blood Authority’s we...

Listen to Tim Brighton with Norman Swan on ABCs Coronacast

You can listen to the ABCs Coronacast podcast from Thursday 3rd June, where THANZ member Tim Brighton speaks to host Norman Swan, here. Tim discusses risk factors, diagnosis, early detection, trea...

THANZ and ATAGI issue joint statement

The THANZ and the Australian Technical Advisory Group on Immunisation (ATAGI)  joint statement on  Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZenecThe s...

VITT Multidisciplinary Guideline for Doctors

The multidisciplinary VITT Communication Committee has developed and endorsed a  VITT guideline for doctors. The guideline has also been endorsed by the THANZ VITT Advisory Committee and  we ar...

IVIg available under national blood arrangements for VITT

The National Blood Authority (NBA) has been monitoring the rapidly evolving situation with regard to vaccine-induced immune thrombotic thrombocytopenia (VITT), otherwise known as thrombosis with th...

Suspected Vaccine Induced Prothrombotic Immune Thrombocytopenia (VIPIT): THANZ Advisory Statement (check for weekly updates)

The THANZ advisory statement on suspected vaccine induced prothrombotic immune thrombocytopenia (VIPIT) has been developed by the THANZ Vaccine Thrombocytopenia Working Group and&nbs...

THANZ and HSANZ joint statement regarding the potential risk of thrombotic/bleeding events after COVID‐19 vaccination

The joint statement is available for members-only to download here.

ATAGI Statement for health care providers on suitability of COVID-19 vaccination in people with history of clotting conditions

The full statement can be found here and the text is reproduced below. “Following the ATAGI statement of 19 March 2021 on the safety of the AstraZeneca COVID-19 vacci...

VTE Prevention: Implementationm guide

Venous thromboembolism (VTE) remains among the 20 most frequently occurring hospital acquired complications [1]. The Australian Commission for Quality and Safety in Health Care (ACQSHC) h...

NC19CET CPR Flow Charts

The National COVID-19 Clinical Evidence Taskforce has today issued guidance on CPR during the pandemic. Healthcare workers and trained first aid responders are being urged not to delay commencing...

Preventing Another Clot

The THANZ Education Committee has developed a patient information leaflet aimed at preventing another clot. The leaflet, which is being launched to coincide with World Thrombosis Day, 13th Oct...

ISTH and THANZ COVID-19 and VTE Consensus Statement

Emerging research has shown that patients who are hospitalized with COVID-19 have a high risk of  developing a venous thromboembolism or VTE. A  consensus statement has been issued b...

Clinical Trails Group Funding Available

The THANZ Clinical Trials Group (CTG) is now accepting applications from THANZ members for grants to support T&H clinical trials. Each year there will be a maximum of $80,000 of grants availab...

ACSQHC VTE Clinical Care Standard

More information about the Clinical Care Standard, which is endorsed by THANZ,  can be found here

New Patient Information Resources Published

New Patient Information Resources Published

The THANZ Education Committee has launched a new series of on-line patient information leaflets covering  Deep Vein Thrombosis Anti thrombin deficiency Factor V Leiden gene mutation Protein C defi...

NPAAC revised publications

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requir...

NPAAC revised publications

Five revised accreditation standards have been published and will come in to effect on 1 December 2018. For more information and to download the revised documents head to the NPAAC web siteP Requir...

ANZSBT Guidelines for the Administration of Blood Products

The ANZSBT has released of the Guidelines for the Administration of Blood Products, 3rd Edition, 2018. These guidelines were developed by the Clinical Practice Improvement Committee ...

Patient Blood Management Guidelines

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

Patient Blood Management Guidelines

The latest Patient Blood Management Guideline progress update is available from the National Blood Authority

Call for Research Projects and Supervisors

The following ASTH members have provided their research topics and availability for supervision. If you’re interested in adding your name to this list please contact asth@bigpond.com. Members ca...

The THANZ Story

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled...

Our Sponsors

2024 Corporate Sponsor

THANZ receives financial assistance from the following corporate supporter
© 2024
 Thrombosis & Haemostasis Society of Australia and New Zealand